Table 4 CCL3 levels in different... | American Society of Hematology

Table 4

CCL3 levels in different prognostic subgroups

Characteristic	CCL3, pg/mL
RAI stage
0/I/II	25.7 ± 45.8*
III/IV	65.7 ± 114.9
Mutational status
IgV_H mutated	14.4 ± 28.5*
IgV_H unmutated	55.8 ± 95.7
CD38
Negative	22.5 ± 44.6*
Positive	55.8 ± 77.6
ZAP-70
Negative	17 ± 36.1*
Positive	53.1 ± 89
β₂-microglobulin
< 4 mg/L	17.4 ± 28.8*
≥ 4 mg/L	78.2 ± 111.2
White blood cell count
< 100 000	28.7 ± 63.9*
> 100 000	50.1 ± 73.2
Cytogenetics
del 13q	16.1 ± 30.6†
Diploid	38.0 ± 80.9
Trisomy 12q	44.5 ± 111.8
del 11q	51.5 ± 64.6
del 17p	55.1 ± 75.5

Characteristic	CCL3, pg/mL
RAI stage
0/I/II	25.7 ± 45.8*
III/IV	65.7 ± 114.9
Mutational status
IgV_H mutated	14.4 ± 28.5*
IgV_H unmutated	55.8 ± 95.7
CD38
Negative	22.5 ± 44.6*
Positive	55.8 ± 77.6
ZAP-70
Negative	17 ± 36.1*
Positive	53.1 ± 89
β₂-microglobulin
< 4 mg/L	17.4 ± 28.8*
≥ 4 mg/L	78.2 ± 111.2
White blood cell count
< 100 000	28.7 ± 63.9*
> 100 000	50.1 ± 73.2
Cytogenetics
del 13q	16.1 ± 30.6†
Diploid	38.0 ± 80.9
Trisomy 12q	44.5 ± 111.8
del 11q	51.5 ± 64.6
del 17p	55.1 ± 75.5

Mean CCL3 levels were significantly higher in patients with poor prognostic features.

P < .01.

P < .05.